Effects of environmental enrichment and paradoxical sleep deprivation on open-field behavior of amphetamine-treated mice

被引:19
作者
Fukushiro, Daniela Fukue
Calzavara, Mariana Bendlin
Trombin, Thais Fernanda
Lopez, Giorgia Badle
Abilio, Vanessa Costhek
Andersen, Monica Levy
Tufik, Sergio
Frussa-Filho, Roberto
机构
[1] Univ Fed Sao Paulo, Dept Farmacol, BR-04023062 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil
关键词
environmental enrichment; paradoxical sleep deprivation; amphetamine; open-field behavior; C57BL/6; mice;
D O I
10.1016/j.physbeh.2007.06.002
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Environmental enrichment or paradoxical sleep deprivation (PSD) has been shown to modify some responses elicited by drugs of abuse. The aims of the present study were to examine the effects of environmental enrichment and PSD, conducted separately or in association, on open-field behavior elicited by amphetamine (AMP) in mice. Methods: Male C57BL/6 mice were randomly assigned to live in either an enriched environmental condition (EC) or a standard environmental condition (SC) for 12 months since weaning. Some of the EC and SC mice were sleep deprived for 48 h, while others were maintained in their home-cages. Immediately after PSD or home-cage stay, the animals received an ip injection of saline, 2.5 mg/kg AMP or 5.0 mg/kg AMP. Fifteen minutes later, their open-field behavior was quantified. Results: Whereas PSD enhanced total and peripheral locomotor activity of acutely AMP-treated mice, environmental enrichment presented only a trend toward enhancement. When PSD and environmental enrichment were combined, an increase in the total and peripheral locomotion frequencies of AMP-treated animals, similar to that observed after PSD, was revealed. In addition, PSD, environmental enrichment or their combination did not modify the effects of AMP on the other open-field behavioral parameters that were analyzed. Conclusion: The present findings demonstrate that some (but not all) of the behavioral effects caused by AMP acute administration can be similarly and specifically enhanced by both environmental enrichment and PSD in C57BL/6 mice. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 55 条
[1]  
ALVAREZ JN, 2006, PHARM BIOCH BEHAV, V83, P500, DOI DOI 10.1016/J.PBB.2006.03.010
[2]   Acute cocaine effects in paradoxical sleep deprived male rats [J].
Andersen, ML ;
Perry, JC ;
Tuflk, S .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02) :245-251
[3]   Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice [J].
Araujo, NP ;
Andersen, ML ;
Abílio, VC ;
Gomes, DC ;
Carvalho, RC ;
Silva, RH ;
Ribeiro, RD ;
Tufik, S ;
Frussa, R .
BRAIN RESEARCH BULLETIN, 2006, 69 (03) :332-337
[4]   The importance of housing conditions on behavioral sensitization and tolerance to ethanol [J].
Araujo, NP ;
Camarini, R ;
Souza-Formigoni, MLO ;
Carvalho, RC ;
Abílio, VC ;
Silva, RH ;
Ricardo, VP ;
Ribeiro, RD ;
Frussa-Filho, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 82 (01) :40-45
[5]   EFFECTS OF LITHIUM ON DOPAMINE BEHAVIORAL SUPERSENSITIVITY INDUCED BY RAPID EYE-MOVEMENT SLEEP-DEPRIVATION [J].
ARRIAGA, F ;
DUGOVIC, C ;
WAUQUIER, A .
NEUROPSYCHOBIOLOGY, 1988, 20 (01) :23-27
[6]  
Bardo MT, 1999, PSYCHOBIOLOGY, V27, P292
[7]   Effect of differential rearing environments on morphine-induced behaviors, opioid receptors and dopamine synthesis [J].
Bardo, MT ;
Robinet, PM ;
Hammer, RF .
NEUROPHARMACOLOGY, 1997, 36 (02) :251-259
[8]   ENVIRONMENTAL ENRICHMENT ATTENUATES LOCOMOTOR SENSITIZATION, BUT NOT IN-VITRO DOPAMINE RELEASE, INDUCED BY AMPHETAMINE [J].
BARDO, MT ;
BOWLING, SL ;
ROWLETT, JK ;
MANDERSCHEID, P ;
BUXTON, ST ;
DWOSKIN, LP .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (2-3) :397-405
[9]  
Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278
[10]   Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol [J].
Bellot, RG ;
Camarini, R ;
Vital, MABF ;
PalermoNeto, J ;
Leyton, V ;
Frussa, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (03) :175-179